Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Multiple Myeloma 24Burkitt Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Mantle-Cell 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Biphenotypic, Acute 3Smoldering Multiple Myeloma 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Plasma Cell 2Brain Neoplasms 2Blast Crisis 2Renal Insufficiency 1Recurrence 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmacytoma 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Accelerated Phase 1Immunoglobulin Light-chain Amyloidosis 1Hodgkin Disease 1Dyspnea 1Down Syndrome 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1

Interventions

Surveys and Questionnaires 4Dexamethasone 2Calcium Dobesilate 2dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Tiotropium Bromide 1Sugars 1Respiratory Therapy 1Oxygen 1Midazolam 1Lisinopril 1Dexmedetomidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Dyspnea × auricularum × Clear all
NCT03367156 2025-11-12

Dexamethasone in Controlling Dyspnea in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
135 enrolled 19 charts
Other

Dyspnea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡